These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5594383)

  • 41. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)].
    Ochiai T; Fukuchi I; Ego H; Yamamura M; Kudo Y; Ishida R
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic properties of N-oxides of certain antihistaminic drugs.
    Gieldanowski J; Prastowski W
    Arch Immunol Ther Exp (Warsz); 1965; 13(6):657-65. PubMed ID: 4379532
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacology of clovoxamine, a new non-tricyclic antidepressant.
    Claassen V; Boschman TA; Dhasmana KM; Hillen FC; Vaatstra WJ; Zwagemakers JM
    Arzneimittelforschung; 1978; 28(10):1756-66. PubMed ID: 582680
    [No Abstract]   [Full Text] [Related]  

  • 44. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific sites of action of snake venoms in the central nervous system.
    Bicher HI
    Mem Inst Butantan; 1966; 33(2):523-39. PubMed ID: 6002425
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction of toxic venoms with the complement system.
    Birdsey V; Lindorfer J; Gewurz H
    Immunology; 1971 Aug; 21(2):299-310. PubMed ID: 4398349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Specific and aspecific activity of an antihistaminic of the H1 type: HC 20-511 or ketothiphen (benzo-cyclohepta-thiophenone derivative)].
    Lampa E; Apolito A; Russo G; Pedone P; Alise G
    Boll Chim Farm; 1977 Nov; 116(11):644-63. PubMed ID: 28130
    [No Abstract]   [Full Text] [Related]  

  • 48. [Experimental anti-asthmatic activity of morpholinomethyltheophylline].
    Vertua R; Caffau S
    Arch Ital Sci Farmacol; 1965; 15(1):111-3. PubMed ID: 5871009
    [No Abstract]   [Full Text] [Related]  

  • 49. A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.
    Nelson RA
    Surv Ophthalmol; 1966 Aug; 11(4):498-505. PubMed ID: 5919620
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacology of crystalline crotoxin. I. Toxicity.
    Brazil OV; Franceschi JP; Waisbich E
    Mem Inst Butantan; 1966; 33(3):973-80. PubMed ID: 4974700
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmacological study of reumycin].
    Veĭs RA; Storozhsev IA
    Antibiotiki; 1968 Nov; 13(11):1014-21. PubMed ID: 5712468
    [No Abstract]   [Full Text] [Related]  

  • 52. [To the analysis of the action of carboxamide derivatives of tetracycline on the cardiovascular system].
    Grinberg GE
    Antibiotiki; 1967 Sep; 12(9):837-41. PubMed ID: 5585719
    [No Abstract]   [Full Text] [Related]  

  • 53. Respiratory and cardiovascular effects of 3-methylxanthine, a metabolite of theophylline.
    Persson CG; Andersson KE
    Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):529-36. PubMed ID: 577111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experimental studies of the specificity and aspecificity of a beta-adrenolytic agent, bunitrolol (Kö 1366)].
    Marmo E; Lampa E; Rossi F; Caputi AP; Chieppa S; Vacca C; Giordano L; Pedone P
    Arch Sci Med (Torino); 1978; 135(1):15-56. PubMed ID: 25057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The testing of the new spasmolytic benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate in the clinic and practice].
    Schenck EG; Michael G
    Arzneimittelforschung; 1966 Aug; 16(8):939-88. PubMed ID: 4870012
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacological properties of cardiotoxin isolated from the venom of Naja naja atra.
    Lee CY; Chang CC; Chiu TH; Tseng TC; Lee SY
    Mem Inst Butantan; 1966; 33(3):1009. PubMed ID: 6002954
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
    Hoefke W; Kobinger W
    Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experimental study of kanamycin aerosols].
    Prokhorova II; Eĭdel'shmeĭn SI; Berezina EK
    Antibiotiki; 1968 Dec; 13(12):1115-8. PubMed ID: 5720237
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiovascular and respiratory effects of cobra venom and a venom fraction.
    Cohen M; Sumyk GB
    Toxicon; 1966 Apr; 3(4):291-5. PubMed ID: 5925219
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental research on a new respiratory analeptic: almitrine].
    Montinaro C; De Gennaro G; Scafuro MA; Spaziante G; Ruta A; Ruggiero E; D'Angelo G; Spadaro R; De Marco G
    Minerva Anestesiol; 1982 Jun; 48(6):373-82. PubMed ID: 6127655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.